Insider Selling: Tenet Healthcare (NYSE:THC) Director Sells $1,300,146.30 in Stock

Tenet Healthcare Corporation (NYSE:THC) Director Tammy Romo sold 4,922 shares of the company’s stock in a transaction on Thursday, August 6th. The shares were sold at an average price of $264.15, for a total transaction of $1,300,146.30. Following the completion of the transaction, the director owned 30,784 shares of the company’s stock, valued at approximately $8,131,593.60. The trade was a 13.78% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website.

Tammy Romo also recently made the following trade(s):

• On Friday, August 7th, Tammy Romo sold 2,500 shares of Tenet Healthcare stock. The stock was sold at an average price of $260.83, for a total transaction of $652,075.00.

Tenet Healthcare Stock Performance

NYSE THC opened at $266.87 on Thursday. The company has a fifty day moving average of $205.96 and a two-hundred day moving average of $202.93. The company has a debt-to-equity ratio of 2.00, a current ratio of 1.41 and a quick ratio of 1.35. Tenet Healthcare Corporation has a 1 year low of $157.58 and a 1 year high of $269.31. The company has a market capitalization of $21.49 billion, a PE ratio of 10.29, a P/E/G ratio of 0.99 and a beta of 1.23.

Tenet Healthcare (NYSE:THC) last announced its earnings results on Thursday, July 23rd. The company reported $6.12 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.26 by $1.86. The firm had revenue of $6.04 billion during the quarter, compared to analysts’ expectations of $5.43 billion. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%.The business’s revenue was up 6.8% on a year-over-year basis. During the same period in the prior year, the firm earned $4.02 EPS. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. As a group, analysts expect that Tenet Healthcare Corporation will post 21.07 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on THC. The Goldman Sachs Group reiterated a “buy” rating and set a $305.00 price target on shares of Tenet Healthcare in a research note on Tuesday, July 28th. Stephens reissued an “overweight” rating and set a $285.00 price target on shares of Tenet Healthcare in a report on Monday, July 27th. Wall Street Zen raised Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Monday, August 3rd. Raymond James Financial set a $270.00 target price on Tenet Healthcare in a report on Monday, July 27th. Finally, Piper Sandler set a $308.00 price target on Tenet Healthcare in a report on Monday, July 27th. Seventeen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $272.25.

Institutional Trading of Tenet Healthcare

A number of institutional investors have recently modified their holdings of the business. Price T Rowe Associates Inc. MD raised its position in Tenet Healthcare by 1.6% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 7,490,350 shares of the company’s stock worth $1,488,484,000 after acquiring an additional 119,809 shares in the last quarter. Boston Partners lifted its stake in shares of Tenet Healthcare by 15.7% in the fourth quarter. Boston Partners now owns 3,642,136 shares of the company’s stock valued at $723,804,000 after purchasing an additional 494,581 shares during the period. AQR Capital Management LLC grew its position in Tenet Healthcare by 20.3% during the fourth quarter. AQR Capital Management LLC now owns 2,256,539 shares of the company’s stock worth $448,419,000 after buying an additional 380,116 shares during the period. Ameriprise Financial Inc. grew its holdings in shares of Tenet Healthcare by 8.0% in the 2nd quarter. Ameriprise Financial Inc. now owns 2,119,423 shares of the company’s stock worth $373,020,000 after acquiring an additional 157,109 shares during the period. Finally, Norges Bank purchased a new position in Tenet Healthcare in the 4th quarter valued at approximately $248,494,000. 95.44% of the stock is currently owned by hedge funds and other institutional investors.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.